Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

Topical Sildenafil as Pre-Treatment for Hand-Foot Skin Reaction

Early Phase 1

Completed

Conditions: Hand Foot Skin Reaction

Interventions: Drug: Sildenafil

First Posted Date: 2017-07-25

Last Posted Date: 2021-11-01

Lead Sponsor: Northwestern University

Target Recruit Count: 2

Registration Number: NCT03229512

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸
Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Gene Expression and Biomarker Profiling of Keloid Skin

Not Applicable

Completed

Conditions: Keloid
Keloid of Ear Lobe
Healthy Adults

Interventions: Procedure: Biopsy and/or triamcinolone injection
Procedure: Excisional Biopsy

First Posted Date: 2017-07-25

Last Posted Date: 2023-03-29

Lead Sponsor: Northwestern University

Target Recruit Count: 48

Registration Number: NCT03228693

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine Department of Dermatology, Chicago, Illinois, United States

Dermatologic Manifestations of Zika Virus

Withdrawn

Conditions: Zika Virus Symptoms and the Associated Exanthema

First Posted Date: 2017-07-25

Last Posted Date: 2019-02-04

Lead Sponsor: Northwestern University

Registration Number: NCT03229421

Locations: 🇩🇴
Pontificia Universidad Catolica Madre y Maestra, Departamento de Medicina, Santo Domingo, Illinois, Dominican Republic

PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma

Phase 2

Active, not recruiting

Conditions: Classical Hodgkin Lymphoma
Mixed Cellularity Classical Hodgkin Lymphoma
Lymphocyte-Depleted Classical Hodgkin Lymphoma
Lymphocyte-Rich Classical Hodgkin Lymphoma
Nodular Sclerosis Classical Hodgkin Lymphoma

Interventions: Procedure: Computed Tomography
Drug: Dacarbazine
Drug: Doxorubicin Hydrochloride
Radiation: Fludeoxyglucose F-18
Other: Laboratory Biomarker Analysis
Biological: Pembrolizumab
Procedure: Positron Emission Tomography
Drug: Vinblastine Sulfate

First Posted Date: 2017-07-21

Last Posted Date: 2023-06-02

Lead Sponsor: Northwestern University

Target Recruit Count: 30

Registration Number: NCT03226249

Locations: 🇺🇸
Stanford Cancer Institute, Stanford, California, United States
🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States

and more 1 locations

Myoelectric Upper Limb Orthosis Use by Persons With TBI and Stroke

Not Applicable

Completed

Conditions: Traumatic Brain Injury
Stroke

Interventions: Device: MyoPro Motion-G
Other: Motor Learning-Based Therapy

First Posted Date: 2017-07-12

Last Posted Date: 2021-07-15

Lead Sponsor: Northwestern University

Target Recruit Count: 16

Registration Number: NCT03215771

Locations: 🇺🇸
Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, United States

Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer

Phase 2

Recruiting

Conditions: Estrogen Receptor Positive
HER2/Neu Negative
Recurrent Breast Carcinoma
Estrogen Receptor Negative
Progesterone Receptor Negative
Stage IV Breast Cancer
Triple-Negative Breast Carcinoma

Interventions: Drug: Carboplatin
Other: Laboratory Biomarker Analysis
Biological: Pembrolizumab

First Posted Date: 2017-07-11

Last Posted Date: 2021-05-03

Lead Sponsor: Northwestern University

Target Recruit Count: 100

Registration Number: NCT03213041

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Nilotinib in Parkinson's Disease

Phase 2

Completed

Conditions: Parkinson Disease

Interventions: Drug: Placebo

First Posted Date: 2017-07-02

Last Posted Date: 2020-07-22

Lead Sponsor: Northwestern University

Target Recruit Count: 76

Registration Number: NCT03205488

Locations: 🇺🇸
Albany Medical College, Albany, New York, United States
🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

and more 21 locations

Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®

Terminated

Conditions: Hepatocellular Carcinoma

Interventions: Other: Plasma collection

First Posted Date: 2017-06-29

Last Posted Date: 2020-09-09

Lead Sponsor: Northwestern University

Target Recruit Count: 4

Registration Number: NCT03203837

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Effectiveness of Physiologic Testing in PPI Non-Responders

Early Phase 1

Completed

Conditions: Gastro Esophageal Reflux

Interventions: Drug: dexlansoprazole

First Posted Date: 2017-06-28

Last Posted Date: 2023-01-12

Lead Sponsor: Northwestern University

Target Recruit Count: 240

Registration Number: NCT03202537

Locations: 🇺🇸
Northwestern Memorial Health Care, Chicago, Illinois, United States

Assessment of Dermatologists at Skin of Color Clinics

Completed

Conditions: Characteristics of Dermatologists Who Focus on Ethnic Skin

First Posted Date: 2017-06-28

Last Posted Date: 2017-12-13

Lead Sponsor: Northwestern University

Target Recruit Count: 33

Registration Number: NCT03201029

Locations: 🇺🇸
Northwestern University Department of Dermatology, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy